PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis:… EP News Bureau Jun 6, 2025 As current IPF treatments face adoption and efficacy challenges, GlobalData highlights LYT-100’s potential to address unmet needs…
